Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Positron Emission Tomography: applications in drug discovery and drug development.

Wang J, Maurer L.

Curr Top Med Chem. 2005;5(11):1053-75. Review.

PMID:
16181131
2.

Microwave accelerated labeling methods in the synthesis of radioligands for positron emission tomography imaging.

Kallmerten AE, Alexander A, Wager KM, Jones GB.

Curr Radiopharm. 2011 Oct;4(4):343-54. Review.

PMID:
22202157
3.

Iodine-124: a promising positron emitter for organic PET chemistry.

Koehler L, Gagnon K, McQuarrie S, Wuest F.

Molecules. 2010 Apr 13;15(4):2686-718. doi: 10.3390/molecules15042686. Review.

4.

Small-animal positron emission tomography as a tool for neuropharmacology.

Lancelot S, Zimmer L.

Trends Pharmacol Sci. 2010 Sep;31(9):411-7. doi: 10.1016/j.tips.2010.06.002. Epub 2010 Jul 6. Review.

PMID:
20599282
5.

Small animal PET in preclinical studies: opportunities and challenges.

Riemann B, Schäfers KP, Schober O, Schäfers M.

Q J Nucl Med Mol Imaging. 2008 Sep;52(3):215-21. Review.

7.

Small animal PET imaging.

Hutchins GD, Miller MA, Soon VC, Receveur T.

ILAR J. 2008;49(1):54-65.

PMID:
18172333
8.

[Application of pre-clinical PET imaging for drug development].

Tsukada H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):231-7. Review. Japanese.

PMID:
22256612
9.

The use of imaging in preclinical drug development.

Vanderheyden JL.

Q J Nucl Med Mol Imaging. 2009 Aug;53(4):374-81.

10.

Target-specific delivery of peptide-based probes for PET imaging.

Chen K, Conti PS.

Adv Drug Deliv Rev. 2010 Aug 30;62(11):1005-22. doi: 10.1016/j.addr.2010.09.004. Epub 2010 Sep 17. Review.

PMID:
20851156
11.

Positron emitting tracers in pre-clinical drug development.

Fernandes E, Barbosa Z, Clemente G, Alves F, Abrunhosa AJ.

Curr Radiopharm. 2012 Apr;5(2):90-8. Review.

PMID:
22280107
12.

Fundamentals of positron emission tomography and applications in preclinical drug development.

Cherry SR.

J Clin Pharmacol. 2001 May;41(5):482-91. Review.

PMID:
11361044
13.

Positron emission tomography for modeling pathophysiological processes in vivo.

Hendrikse NH, Luurtsema G, van der Veldt AA, Lubberink M.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):717-25. Review.

PMID:
18729023
14.

Production of iodine-124 and its applications in nuclear medicine.

Braghirolli AM, Waissmann W, da Silva JB, dos Santos GR.

Appl Radiat Isot. 2014 Aug;90:138-48. doi: 10.1016/j.apradiso.2014.03.026. Epub 2014 Apr 4. Review.

PMID:
24747530
15.

Preclinical anatomical, molecular, and functional imaging of the lung with multiple modalities.

Gammon ST, Foje N, Brewer EM, Owers E, Downs CA, Budde MD, Leevy WM, Helms MN.

Am J Physiol Lung Cell Mol Physiol. 2014 May 15;306(10):L897-914. doi: 10.1152/ajplung.00007.2014. Epub 2014 Mar 21. Review.

16.

[Positron emission tomography: a clinical and biological research tool].

Kotzki PO.

J Soc Biol. 2004;198(2):163-8. Review. French.

PMID:
15368968
17.

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

Shokeen M, Anderson CJ.

Acc Chem Res. 2009 Jul 21;42(7):832-41. doi: 10.1021/ar800255q.

18.

Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders.

Yoshinaga K, Chow BJ, dekemp RA, Thorn S, Ruddy TD, Davies RA, DaSilva JN, Beanlands R.

Curr Pharm Des. 2005;11(7):903-32. Review.

PMID:
15777243
19.

The next generation of positron emission tomography radiopharmaceuticals in oncology.

Rice SL, Roney CA, Daumar P, Lewis JS.

Semin Nucl Med. 2011 Jul;41(4):265-82. doi: 10.1053/j.semnuclmed.2011.02.002. Review.

20.

A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging.

Bagci U, Foster B, Miller-Jaster K, Luna B, Dey B, Bishai WR, Jonsson CB, Jain S, Mollura DJ.

EJNMMI Res. 2013 Jul 23;3(1):55. doi: 10.1186/2191-219X-3-55.

Supplemental Content

Support Center